1. Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway
   Jiao Fu et al, 2013, BMC Cancer CrossRef
2. Identification of the collagen type 1 alpha 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma
   Masamichi Hayashi et al, 2014, BMC Cancer CrossRef
3. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma
   Fuqiang Yin et al, 2016, J Exp Clin Cancer Res CrossRef
4. Reduced Expression of Reelin (RELN) Gene Is Associated With High Recurrence Rate of Hepatocellular Carcinoma
   Yukiyasu Okamura et al, 2011, Ann Surg Oncol CrossRef
5. Suppressor of Cytokine Signaling 4 Detected as a Novel Gastric Cancer Suppressor Gene using Double Combination Array Analysis
   Daisuke Kobayashi et al, 2012, World J Surg CrossRef
6. Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.
   Mitsuro Kanda et al, 2015, Gastric Cancer CrossRef
7. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma
   Satoshi Sueoka et al, 2015, Ann Surg Oncol CrossRef
8. The two faces of metallothionein in carcinogenesis: photoprotection against UVR-induced cancer and promotion of tumour survival
   Heather M. McGee et al, 2010, Photochem. Photobiol. Sci. CrossRef
9. DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma
   Silvia Udali et al, 2015, Clin Epigenet CrossRef
10. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression.
    Wen Cai Zhang et al, 2016, Nat Commun CrossRef
11. Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer
    Mitsuro Kanda et al, 2014, J Exp Clin Cancer Res CrossRef
12. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
    Mitsuro Kanda et al, 2015, Dig. Dis. Sci. CrossRef
13. Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer
    Mitsuro Kanda et al, 2014, J Exp Clin Cancer Res CrossRef
14. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway
    Yulong Zheng et al, 2017, BMC Cancer CrossRef
15. Advanced glycation end-products stimulate basic fibroblast growth factor expression in cultured Müller cells
    JING AI et al, 2013 CrossRef
16. Highly Synergistic Effect of Sequential Treatment with Epigenetic and Anticancer Drugs To Overcome Drug Resistance in Breast Cancer Cells Is Mediated via Activation of p21 Gene Expression Leading to G2/M Cycle Arrest
    Sivakumar Vijayaraghavalu et al, 2013, Mol. Pharmaceutics CrossRef
17. A study of cryogenic tissue-engineered liver slices in calcium alginate gel for drug testing
    Ruomeng Chen et al, 2018, Cryobiology CrossRef
18. The roles of metallothioneins in carcinogenesis.
    Manfei Si et al, 2018, J Hematol Oncol CrossRef
19. Metallothioneins may be a potential prognostic biomarker for tumors
    Lei Wang et al, 2018, Medicine CrossRef
20. Molecular Aspects of Hepatoblastoma
    Roland Kappler et al, 2011 CrossRef
21. Vascular Endothelial Receptor Tyrosine Phosphatase: Identification of Novel Substrates Related to Junctions and a Ternary Complex with EPHB4 and TIE2
    Hannes C. A. Drexler et al, 2019, Mol Cell Proteomics CrossRef
22. Gefitinib modulates stress fibers and tubular-like structure formation and attenuates angiogenesis in an in vivo chicken model of chorioallantoic membrane angiogenesis
    Tsung-Chieh Lin, 2020, Biochemical and Biophysical Research Communications CrossRef
23. Fes Tyrosine Kinase Expression in the Tumor Niche Correlates with Enhanced Tumor Growth, Angiogenesis, Circulating Tumor Cells, Metastasis, and Infiltrating Macrophages
    Shengnan Zhang et al, 2011, Cancer Res CrossRef
24. Role of metallothioneins in benign and malignant thyroid lesions
    Bartosz Pula et al, 2012, Thyroid Res CrossRef
25. Detection of doublecortin domain-containing 2 (DCDC2), a new candidate tumor suppressor gene of hepatocellular carcinoma, by triple combination array analysis
    Yoshikuni Inokawa et al, 2013, J Exp Clin Cancer Res CrossRef
26. Analysis of lung cancer-related genetic changes in long-term and low-dose polyhexamethylene guanidine phosphate (PHMG-p) treated human pulmonary alveolar epithelial cells
    Hong Lee et al, 2022, BMC Pharmacol Toxicol CrossRef
27. Structure, Polymorphisms and Electrochemistry of Mammalian Metallothioneins – A Review
    Helena Skutkova et al, 2012, International Journal of Electrochemical Science CrossRef
28. In Vitro Assessment of Wound-Healing Efficacy of Stabilized Basic Fibroblast Growth Factor (FGF-2) Solutions
    Leah Benington et al, 2024, Pharmaceuticals CrossRef
29. MT1G Regulates c-MYC/P53 Signal to Inhibit Proliferation, Invasion and Migration and Promote Apoptosis in Colon Cancer Cells
    Jie Li et al, 2024, CMM CrossRef
30. Exosome in renal cell carcinoma progression and implications for targeted therapy
    Xinwei Li et al, 2024, Front. Oncol. CrossRef